D.M. Wright

1.3k total citations
31 papers, 1.1k citations indexed

About

D.M. Wright is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Social Psychology. According to data from OpenAlex, D.M. Wright has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cellular and Molecular Neuroscience, 9 papers in Molecular Biology and 8 papers in Social Psychology. Recurrent topics in D.M. Wright's work include Neuropeptides and Animal Physiology (11 papers), Neuroendocrine regulation and behavior (8 papers) and Pain Mechanisms and Treatments (6 papers). D.M. Wright is often cited by papers focused on Neuropeptides and Animal Physiology (11 papers), Neuroendocrine regulation and behavior (8 papers) and Pain Mechanisms and Treatments (6 papers). D.M. Wright collaborates with scholars based in United Kingdom, Canada and Spain. D.M. Wright's co-authors include J.L. Henry, M.H.T. Roberts, John Bolodeoku, Christopher R. Chapple, Ted Drogendijk, Philip Toozs‐Hobson, Luigi Selvaggi, R. Martínez-García, Nicole Ropert and Petar Polc and has published in prestigious journals such as The Lancet, Brain Research and Pain.

In The Last Decade

D.M. Wright

30 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D.M. Wright United Kingdom	17	442	296	290	267	244	31	1.1k
Derek Chalmers United Kingdom	12	233 0.5×	92 0.3×	174 0.6×	57 0.2×	267 1.1×	18	870
Ulrich Schwantes Germany	16	67 0.2×	520 1.8×	68 0.2×	299 1.1×	156 0.6×	44	894
Yoshito Takahashi Japan	13	102 0.2×	120 0.4×	239 0.8×	61 0.2×	143 0.6×	48	929
Erik Klinge Finland	17	306 0.7×	137 0.5×	232 0.8×	8 0.0×	151 0.6×	55	859
Andrew C. Barrett United States	22	708 1.6×	9 0.0×	488 1.7×	21 0.1×	328 1.3×	60	1.4k
Gianmario Frigo Italy	24	399 0.9×	8 0.0×	249 0.9×	21 0.1×	427 1.8×	48	1.6k
Bradford D. Fischer United States	15	323 0.7×	8 0.0×	193 0.7×	22 0.1×	215 0.9×	36	645
Laurent Diop France	17	336 0.8×	12 0.0×	316 1.1×	15 0.1×	345 1.4×	32	884
S.R. Kottegoda Singapore	15	136 0.3×	38 0.1×	83 0.3×	6 0.0×	129 0.5×	36	610
E. A. Mayer United States	8	76 0.2×	15 0.1×	306 1.1×	15 0.1×	79 0.3×	10	844

Countries citing papers authored by D.M. Wright

Since Specialization

Citations

This map shows the geographic impact of D.M. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.M. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.M. Wright more than expected).

Fields of papers citing papers by D.M. Wright

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.M. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.M. Wright. The network helps show where D.M. Wright may publish in the future.

Co-authorship network of co-authors of D.M. Wright

This figure shows the co-authorship network connecting the top 25 collaborators of D.M. Wright. A scholar is included among the top collaborators of D.M. Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.M. Wright. D.M. Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chapple, Christopher R., Ted Drogendijk, D.M. Wright, & John Bolodeoku. (2007). POS-01.134: Responses to solifenacin in patients >65 years and ≤65 years with overactive bladder syndrome: post-hoc results from the randomised, double-blind STAR study. Urology. 70(3). 232–232. 3 indexed citations

Chapple, Christopher R., Vik Khullar, Roberto Mario Scarpa, et al.. (2007). Treatment Outcomes in the STAR Study: A Subanalysis of Solifenacin 5 mg and Tolterodine ER 4 mg. European Urology. 52(4). 1195–1203. 61 indexed citations

Chapple, Christopher R., R. Martínez-García, Luigi Selvaggi, et al.. (2005). A Comparison of the Efficacy and Tolerability of Solifenacin Succinate and Extended Release Tolterodine at Treating Overactive Bladder Syndrome: Results of the STAR Trial. European Urology. 48(3). 464–470. 246 indexed citations

Ur, Ehud, D.M. Wright, Pierre Bouloux, & Ashley Grossman. (1997). The effects of spiradoline (U‐62066E), a κ‐opioid receptor agonist, on neuroendocrine function in man. British Journal of Pharmacology. 120(5). 781–784. 72 indexed citations

Donaldson, Kirsteen, et al.. (1994). The effect fluvoxamine at steady state on the pharmacokinetics of theophylline after a singe dose in healthy male volunteers. British Journal of Clinical Pharmacology. 37(5). 492. 3 indexed citations

Wright, D.M., et al.. (1994). The cardiovascular and central nervous system effects in the human of U-62066E. European Journal of Clinical Pharmacology. 46(3). 203–7. 48 indexed citations

Fleishaker, Joseph C., et al.. (1994). Effect of age and gender on tirilazad pharmacokinetics in humans. Clinical Pharmacology & Therapeutics. 55(4). 378–384. 62 indexed citations

Douglas, Alison J., Geoffrey D. Clarke, Susan Macmillan, et al.. (1993). Effects of the κ‐opioid agonist U50,488 on parturition in rats. British Journal of Pharmacology. 109(1). 251–258. 19 indexed citations

Wright, D.M.. (1986). Effect of Zinc on Neuronal Activity in the Rat Forebrain. Advances in experimental medicine and biology. 203. 599–609. 6 indexed citations

10.

Wright, D.M.. (1985). Evidence for a spinal site at which opioids may act to inhibit the milk-ejection reflex. Journal of Endocrinology. 106(3). 401–407. 13 indexed citations

11.

Wright, D.M. & Dennis W. Lincoln. (1985). Stress-induced analgesia evoked by intraperitoneal injection of hypertonic saline: Evidence for its occurrence in vasopressin deficient rats. Physiology & Behavior. 34(5). 691–695. 12 indexed citations

12.

Wright, D.M. & Geoffrey D. Clarke. (1984). Inhibition of oxytocin secretion by μ and δ receptor selective enkephalin analogues. Neuropeptides. 5(1-3). 273–276. 6 indexed citations

13.

Wright, D.M.. (1984). Zinc: effect and interaction with other cations in the cortex of the rat. Brain Research. 311(2). 343–347. 28 indexed citations

14.

Warrell, D A, et al.. (1983). MEPTAZINOL DIMINISHES THE JARISCH-HERXHEIMER REACTION OF RELAPSING FEVER. The Lancet. 321(8329). 835–839. 40 indexed citations

15.

Wright, D.M., et al.. (1982). Substance P reduces tail-flick latency: Implications for chronic pain syndromes. Pain. 14(2). 155–167. 123 indexed citations

16.

Polc, Petar, Nicole Ropert, & D.M. Wright. (1981). Ethyl β-carboline-3-car☐ylate antagonizes the action of GABA and benzodiazepines in the hippocampus. Brain Research. 217(1). 216–220. 71 indexed citations

17.

Roberts, M.H.T. & D.M. Wright. (1981). THE EFFECTS OF CHRONIC SECTION OF DORSAL ROOTS ON THE RESPONSIVENESS OF MOTONEURONES TO 5‐HYDROXYTRYPTAMINE AND A SUBSTANCE P ANALOGUE. British Journal of Pharmacology. 73(3). 589–594. 6 indexed citations

18.

Wright, D.M. & Malcolm H.T. Roberts. (1980). Responses of spinal neurones to a substance P analogue, noxious pinch and bradykinin. European Journal of Pharmacology. 64(2-3). 165–167. 28 indexed citations

19.

Wright, D.M. & S. Barasi. (1978). Neuronal responses to bradykinin. Neuropharmacology. 17(12). 1057–1058. 5 indexed citations

20.

Wright, D.M. & M.H.T. Roberts. (1978). Supersensitivity to a substance P analogue following dorsal root section. Life Sciences. 22(1). 19–24. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact